Clinical Trial Update: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial updating results for platinum-based chemotherapy with or without INCMGA00012 (an anti-PD-1 antibody) in metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-squamous Non-small Cell Lung Cancer
• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Incyte Corporation | Conditions: Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-02-06